Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham study

American Journal of Clinical Nutrition

Volumn 75, Issue 1, 2002, Pages 38-46

  Ordovas, Jose M ^a,b,c   Corella, Dolores ^a,b,c   Cupples, L Adrienne ^a,b,c   Demissie, Serkalem ^a,b,c   Kelleher, Alison ^a,b,c   Coltell, Oscar ^a,b,c   Wilson, Peter W F ^a,b,c   Schaefer, Ernst J ^a,b,c   Tucker, Katherine ^a,b,c  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIET; ENVIRONMENTAL FACTOR; FAT INTAKE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; POPULATION GENETICS; PROMOTER REGION;

EID: 0036136232     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/75.1.38     Document Type: Article

References (53)

1. AHA dietary guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association
2. Summary of a scientific conference on preventive nutrition: Pediatrics to geriatrics
3. The genetics of serum lipid responsiveness to dietary interventions
4. Apolipoprotein multigene family: Tandem organization of human apolipoprotein A-I, C-III and A-IV genes
5. Structure and function of apolipoprotein A-I and high-density lipoprotein
6. Atheroprotective mechanisms of HDL
7. Quantitation of plasma apolipoproteins in the primary secondary prevention of coronary artery disease
8. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations
9. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia
10. Influence of apolipoprotein A-I promoter polymorphism on lipid levels and responses to dietary change in Finnish adults
11. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII apo AIV concentrations
12. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls
13. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers
14. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study
15. Interaction between a polymorphism of the Apo A-I promoter region and smoking determines plasma levels of HDL and Apo A-I
16. G→A substitution at position -75 of the apolipoprotein A-I gene promoter - Evidence against a direct effect on HDL cholesterol levels
17. Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol
18. Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: Relation with high-density lipoprotein cholesterol and apoA-I concentrations
19. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: Effect on plasma HDL-cholesterol levels
20. Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency
21. A polymorphism in the human apolipoprotein AI promoter region: A study in hypertriglyceridaemic patients
22. Associations of genotypes at the apoliprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high-density lipoprotein subclasses
23. Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease
24. Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls
25. Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysis
26. Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat
27. Human apolipoprotein A-I gene promoter mutation influences plasma low-density lipoprotein cholesterol response to dietary fat saturation
28. Influence of genetic variation at the apoA-I gene locus on lipid levels and response to diet in familial hypercholesterolemia
29. Dietary polyunsaturated fatty acid regulation of gene transcription
30. Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition
31. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro
32. Compound heterozygosity for an apolipoprotein AI gene promoter mutation and a structural nonsense mutation with apolipoprotein AI deficiency
33. The A/G polymorphism in the -78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency
34. A polymorphism (G →A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency
35. The Framingham Offspring Study. Design and preliminary data
36. An investigation of coronary heart disease in families: The Framingham Offspring Study
37. Epidemiological approaches to heart disease: The Framingham Study
38. Long- and short-term risk of sudden coronary death
39. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
40. Metabolism of apolipoproteins A-I, A-II, and A-IV
41. Enzyme linked immunosorbent assay for human apolipoprotein B
42. A simple salting out procedure for extracting DNA from human nucleated cells
43. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals
44. Effect of dietary fatty acids on serum lipids and lipoproteins: A meta-analysis of 27 trials
45. Comparison of the effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man
46. Individual cholesterol variation in response to a margarine- or butter-based diet
47. Plasma lipid response to hypolipidemic diets in young healthy non-obese men varies with body mass index
48. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction
49. Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins
50. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene
51. Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter
52. Hormonal regulation of apolipoprotein AI
53. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing